SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-08-033687
Filing Date
2008-06-04
Accepted
2008-06-04 17:23:14
Documents
3
Period of Report
2008-06-02
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v116608_8k.htm 8-K 36983
2 v116608_ex99-1.htm EX-99.1 27778
3 GRAPHIC logo.jpg GRAPHIC 19439
  Complete submission text file 0001144204-08-033687.txt   93411
Mailing Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 341 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51531 | Film No.: 08881325
SIC: 2834 Pharmaceutical Preparations